At the recently held conference hosted by OncoDNA in the IPG building (Gosselies, Belgium) Jean-Pol Detiffe (CEO, OncoDNA) and Martine Piccart (Co-founder and chair, BIG) announced the launch of a multi-year analysis program AURORA, conducted by [...]
OncoDNA SA expands its territory with the recent announcement of a supplier agreement with NBCC (National Blood and Cancer Center); a specialized centre for diagnosing and treating blood diseases and cancers located in Riyadh, Saudi Arabia, [...]
For the first time, a new form of targeted radiotherapy, or PRRT (Peptide Receptor Radio Therapy) using Lutetium-177 octreotate is available in Belgium. Thanks to a long-term endeavour of logistics, processes and national approval issues, this [...]